MOESM1 of Safety and efficacy of the choline analogue SAR97276 for malaria treatment: results of two phase 2, open-label, multicenter trials in African patients

Held, Jana; Supan, Christian; Salazar, Carmen; Tinto, Halidou; Bonkian, LĂŠa; Nahum, Alain; SiĂŠ, Ali; Abdulla, Salim; Cantalloube, Cathy; Djeriou, Elhadj; Bouyou-Akotet, Marielle; Ogutu, Bernhards; MordmĂźller, Benjamin; Kreidenweiss, Andrea; Siribie, Mohamadou; Sirima, Sodiomon; Kremsner, Peter

doi:10.6084/m9.figshare.c.3772109_D1.v1

12936_2017_1832_MOESM1_ESM.docx (26.94 kB)

MOESM1 of Safety and efficacy of the choline analogue SAR97276 for malaria treatment: results of two phase 2, open-label, multicenter trials in African patients

journal contribution

posted on 2017-05-04, 05:00 authored by Jana Held, Christian Supan, Carmen Salazar, Halidou Tinto, LĂŠa Bonkian, Alain Nahum, Ali SiĂŠ, Salim Abdulla, Cathy Cantalloube, Elhadj Djeriou, Marielle Bouyou-Akotet, Bernhards Ogutu, Benjamin MordmĂźller, Andrea Kreidenweiss, Mohamadou Siribie, Sodiomon Sirima, Peter Kremsner

Additional file 1. Detailed inclusion and exclusion criteria of Study 1 and Study 2.

Funding

Sanofi

History

Usage metrics

Keywords

Malaria P. falciparum SAR97276A Choline analogue Phase 2 Africa

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

MOESM1 of Safety and efficacy of the choline analogue SAR97276 for malaria treatment: results of two phase 2, open-label, multicenter trials in African patients

Funding

Sanofi

History

Usage metrics

Categories

Keywords

Licence

Exports